Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
604 results about "Upper urinary tract infection" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
A urinary tract infection (UTI) is an infection caused by bacteria in part of the urinary tract. In the lower urinary tract, it is known as a simple cystitis (a bladder infection). In the upper urinary tract, it is known as pyelonephritis (a kidney infection).
Closed system irrigation connector for urinary catheters
ActiveUS20060064065A1Reducing potential urinary tract infectionReduce leakageInfusion devicesSurgeryUrinary catheterUpper urinary tract infection
A closed system irrigation connector for use with both 3-way and 2-way urinary catheters is disclosed. The connector fits all urinary catheters and accepts continuous irrigation sets as well as all bulb, piston, and Toomey catheter tip irrigation syringes. The connector eliminates the use of catheter plugs and reduces the mess and leakage often associated with present urinary catheter irrigation procedures. The connector converts an open procedure to a closed system procedure protecting the patient from outside contamination to reduce urinary tract infections as well as the clinician from potentially infectious body fluids. It comprises an assembly of a plastic housing with an internal silicone diaphragm slit valve and a plastic entrance port that are unitized in assembly by sonic welding. The entrance port forms a tapered wedge lock engagement with irrigation sets as well as catheter tip irrigation syringes.
Owner:DALE MEDICAL PRODS
Lateral Flow Device for Attachment to an Absorbent Article
InactiveUS20080269707A1Vaccination/ovulation diagnosticsDisease diagnosisUpper urinary tract infectionControl zone
A lateral flow device for testing a bodily fluid, such as urine, blood, mucous, saliva, etc., is provided. The lateral flow device is configured to be attached to an absorbent article via an attachment mechanism located on the lateral flow device or the absorbent article. The lateral flow device includes a chromatographic medium (e.g., porous membrane) that defines a detection zone that provides a signal indicative of the presence or absence of the analyte. The device may also include a control zone that provides a signal indicative of whether a sufficient amount of bodily fluid has been provided and tested. Regardless of its specific configuration, the lateral flow device is configured to be attached onto the absorbent article to provide a user or caregiver with rapid information about a health condition. For example, the device may be attached onto a diaper to provide information about the presence of enzymes or other compounds often encountered with a patient having a urinary tract infection. This information may provide an early warning system to allow the user or caregiver to seek additional testing and / or treatment. Alternatively, semi-quantitative or quantitative results may be derived from the test.
Owner:KIMBERLY-CLARK WORLDWIDE INC
Assembly for the preparation of a medical device having a coating comprising hydrogen peroxide
InactiveUS20060263404A1Maintain good propertiesEliminate the effects ofPeroxide active ingredientsPretreated surfacesUrinary catheterUpper urinary tract infection
The present invention provides an assembly for the preparation of a medical device having a porous coating comprising hydrogen peroxide. Particularly interesting medical devices are catheters (such as urinary catheters), endoscopes, laryngoscopes, tubes for feeding, tubes for drainage, guide wires, condoms, urisheaths, barrier coatings e.g. for gloves, stents and other implants, extra corporeal blood conduits, membranes e.g. for dialysis, blood filters, devices for circulatory assistance, dressings for wound care, and ostomy bags. The coating is in particular a hydrophilic coating formed from cross-linked polyvinylpyrrolidone. In one embodiment, the assembly holds a dry catheter element in one compartment of a package and an aqueous hydrogen peroxide solution in another compartment. The solution may also comprise stabilizers, e.g. chelators, and osmolality increasing agents. The catheter for insertion in the urethra is useful for the treatment, alleviation or prophylaxis of microbial infections such as urinary tract infections (UTI).
Owner:COLOPLAST AS
Absorbent article containing lateral flow assay device
ActiveUS20080103414A1Diagnostic recording/measuringSensorsUpper urinary tract infectionAbsorbent material
An absorbent article that contains a lateral flow assay device for testing a bodily fluid, such as urine, blood, mucous, saliva, etc., is provided. The lateral flow assay device includes a chromatographic medium (e.g., porous membrane) that defines a detection zone that provides a signal indicative of the presence or absence of the analyte. The device may also include a control zone that provides a signal indicative of whether a sufficient amount of bodily fluid has been provided and tested. Regardless of its specific configuration, the lateral flow assay device is integrated into the absorbent article to provide a user or caregiver with rapid information about a health condition. For example, the device may be integrated into a diaper to provide information about the presence of enzymes or other compounds often encountered with a patient having a urinary tract infection. This information may provide an early warning system to allow the user or caregiver to seek additional testing and / or treatment. Alternatively, semi-quantitative or quantitative results may be derived from the test.
Owner:KIMBERLY-CLARK WORLDWIDE INC
Methods and devices for preventing catheter related urinary tract infections
ActiveUS8911424B2Facilitated releaseSecure attachmentWound drainsCatheterUrinary catheterUpper urinary tract infection
Owner:ETHICON INC
Method of administering FimH protein as a vaccine for urinary tract infections
InactiveUS20030138449A1Reduce morbidityInhibit bindingAntibacterial agentsBacterial antigen ingredientsDiseaseBacteroides
The present invention relates to methods of stimulating an immune response in a primate utilizing compositions comprising bacterial adhesin proteins and / or immunogenic fragments thereof. The compositions are useful for the prevention and treatment of bacterial induced diseases involving bacterial adherence to a target cell, such as diseases of the urinary tract. More specifically, the invention relates to the vaccination of primates, preferably humans, with protein complexes, such as a purified FimH polypeptides, a purified FimC-FimH (FimCH) polypeptide complex, or immunogenic fragments thereof, to stimulate protective immunity in the recipient against infection by pathogenic bacteria, including all types of Enterobacteriaceae, preferably E. coli to produce specific immunoglobin molecules in the serum and urine or mucosal secretions of the subject.
Owner:MEDIMMUNE LLC
Catheter system for minimizing retrograde bacterial transmission from a catheter tubing
InactiveUS20070161949A1Risk minimizationMinimizing likelihood of infectingMedical devicesCatheterUpper urinary tract infectionPressure difference
The present invention provides systems and methods for minimizing the retrograde transmission from the catheter tubing. The invention is particularly suitable for reducing the likelihood of a patient acquiring a urinary tract infection associated with an indwelling catheter. The systems and methods include a catheter tubing having a proximal and distal end with a filter located therebetween and a means for accessing negative pressure for creating a pressure differential between the proximal and distal ends of the catheter tubing.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (UTI) using a hypohalous acid composition
Disclosed is a system that prevents the development of infection and biofilm establishment in medical devices in general, and in particular Urinary Tract Infections (UTI), including Catheter-Associated Urinary Tract Infections (CAUTI). The system comprises of a medical device (such as a catheter) and an antimicrobial composition containing an antimicrobial compound. A medical device delivers the composition both to the inside and / or outside portions of the device, as well as to the inside of the bladder itself and to the urethra. Reduction or elimination of the infection may be accomplished by irrigating the medical device, bathing the bladder, or irrigating the bladder with the composition.
Owner:NOVABAY PHARM INC
RFID-tagged urinary catheter
InactiveUS20090281523A1Increase heightEasy to useMechanical/radiation/invasive therapiesData processing applicationsUrinary catheterUpper urinary tract infection
A hand-held RFID scanner appliance is employed to capture and display status of urinary catheters in hospital patients. The patients are provided with RFID wrist bracelets, and catheters are provided with RFID tags, each with a unique identification code. When the nurse performs a catheter insertion, the nurse scans the patient wrist bracelet with the appliance, then scans a selected catheter. After the catheter is successfully inserted, the catheter is scanned a second time. This creates a time stamp, and a data entry is recorded with the patient identity, presence of catheter, and time of insertion. The appliance is synchronized to the hospital server, and the catheterization status of the hospital patients is displayed for the medical practitioners. This process aids in preventing hospital-acquired urinary tract infections.
Owner:SACCO JOHN J +1
Ostomy bag undergarment
A shorts-type undergarment with an inner pocket (1)secured to the waistband (6) having a U-shaped cutout(2) where the flange (8a) of an ostomy bag (8c) is situated. Said inner pocket (1) is attached to the waistband(6) and holds and ostomy bag(8c). At the bottom of the inner pocket (1) is a horizontal strip of oppositely mated Velcro strips(9) which can be detached to allow the exit of the bag's tube to dispose of the accumulated bodily fluids. It has two vertical openings on the front of the shorts. The first opening,4, is located at the bottom of the crotch and extends upward. This opening,5, allows for the insertion of a catheter. The second opening, is an access panel,4, which is opened by pulling back a long vertical strip of Velcro(R), 3, attached to a corresponding strip of oppositely mated Velcro(R), 2, which horizontally extends partially across one front side. The patient is able to retain a high degree of modesty and dignity, when the catheter is attended to by medical personnel. Since the catheter is secured, in a straight pathway, there is a decreased likelihood the patient will develop secondary medical complications like urinary tract infections, discomfort and irritation associated with a catheter which is not properly secured.
Owner:GUPTON KENNETH
Compounds and methods for treating bacterial infections
ActiveUS20120309701A1Reduce resistanceAntibacterial agentsBiocideUpper urinary tract infectionMedicine
Owner:WASHINGTON UNIV IN SAINT LOUIS
Kidney tea extract and its preparing process and application
InactiveCN101143160AOrganic active ingredientsSkeletal disorderSide effectUpper urinary tract infection
The invention discloses a water soluble phenolic acid extract which is obtained by extracting from a medical plant of a clerodendranthus spicatus by the chemical method. The pharmacological experiment testifies that the extract has strong physiological activity and especially has strong physiological activity of resisting the generation of uric acid, and the extract is used for remedying the pain-louse and has good effect of the treatment towards the urinary tract infection or the urinary tract concretion and has little toxic and side effect.
Owner:李云森
Lateral Flow Device for Attachment to an Absorbent Article
ActiveUS20150025347A1Vaccination/ovulation diagnosticsDisease diagnosisUpper urinary tract infectionControl zone
Owner:KIMBERLY-CLARK WORLDWIDE INC
Absorbent article containing lateral flow assay device
An absorbent article that contains a lateral flow assay device for testing a bodily fluid, such as urine, blood, mucous, saliva, etc., is provided. The lateral flow assay device includes a chromatographic medium (e.g., porous membrane) that defines a detection zone that provides a signal indicative of the presence or absence of the analyte. The device may also include a control zone that provides a signal indicative of whether a sufficient amount of bodily fluid has been provided and tested. Regardless of its specific configuration, the lateral flow assay device is integrated into the absorbent article to provide a user or caregiver with rapid information about a health condition. For example, the device may be integrated into a diaper to provide information about the presence of enzymes or other compounds often encountered with a patient having a urinary tract infection. This information may provide an early warning system to allow the user or caregiver to seek additional testing and / or treatment. Alternatively, semi-quantitative or quantitative results may be derived from the test.
Owner:KIMBERLY-CLARK WORLDWIDE INC
Metal complexes of N-heterocyclic carbenes as radiopharmaceuticals and antibiotics
A method for inhibiting microbial growth comprises administering an effective amount of a silver complex of a N-heterocyclic amine. A method for treating cancer cells or a method for imaging one or more tissues of a patient includes administering an effective amount of a complex of a N-heterocyclic amine and a radioactive metal. A method for treating urinary tract infections utilizing silver complexes of N-heterocyclic carbenes. N-heterocyclic carbenes of the present invention may be represented by the formula wherein Z is a heterocyclic group, and R1 and R2 are, independently or in combination, hydrogen or a C1-C12 organic group selected from the group consisting of alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, arylalkyl, alkylaryl, heterocyclic, and alkoxy groups and substituted derivatives thereof.
Owner:THE UNIVERSITY OF AKRON
Composition for prevention or treatment of urinary tract infection
InactiveUS20090175843A1Prevent and reduce and eliminate symptomIncreased fluid intakeAntibacterial agentsOrganic active ingredientsUpper urinary tract infectionMammal
Compositions particularly suitable for preventing or treating urinary tract infections in mammals, especially in humans, comprising a combination of components, the composition comprising an effective amount of: (A) cranberry concentrate, cranberry extract or both; (B) D-mannose; and at least one component selected from the group consisting of: (C) ascorbic acid; (D) bromelain; and (E) inulin. The compositions are preferably in the form of a liquid concentrate such as a beverage drink.
Owner:MEDICAL NUTRITION USA
Urological access undergarment
InactiveUS6014777AEasy accessWithout any changeHandkerchiefsBaby linensUpper urinary tract infectionUrological surgery
A shorts-type undergarment with two vertical openings on the front of the shorts. The first opening, 4, is located at the bottom of the crotch and extends upward. This opening, 4, allows for the insertion of a catheter. The second opening, is an access panel, 1, which is opened by pulling back a long vertical strip of Velcro TM , 3, attached to a corresponding strip of oppositely mated Velcro TM , 2, which horizontally extends partially across one front side. The patient is able to retain a high degree of modesty and dignity, when the catheter is attended to by medical personnel. Since the catheter is secured, in a straight pathway, there is a decreased likelihood the patient will develop secondary medical complications like urinary tract infections, discomfort and irritation associated with a catheter which is not properly secured.
Owner:GUPTON KENNETH
METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST
The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and / or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect. The present disclosure also provides for methods for treating prostate cancer in a patient with a history of at least one cardiovascular event, wherein administration of degarelix to the subject decreases the likelihood of developing or experiencing an additional cardiovascular event compared to treatment with a gonadotrophin releasing hormone (GnRH) agonist.
Owner:FERRING BV
Method of preventing, controlling and ameliorating urinary tract infections using a synergistic cranberry derivative and d-mannose composition
InactiveUS20090226548A1High bulk densityDecrease effective dose volumeAntibacterial agentsBiocideEscherichia coliUpper urinary tract infection
A method is disclosed that prevents, controls and ameliorates urinary tract infections caused by E. coli by administering a therapeutically effective amount of a human dietary supplement composition comprising a cranberry derivative or proanthocyanidin containing concentrate and D-mannose combined in a form suitable for oral consumption. The cranberry derivative or proanthocyanidin containing concentrate comprises from about one percent (1.0%) by weight to about 95 percent (95.0%) by weight on a dry weight basis. The composition is formulated for delivering a D-mannose unit dosage between about 0.5 to about 5.0 grams per dose and further comprising an analgesic or antispasmodic or combination thereof, and optionally a diuretic, and wherein the composition formed from the cranberry derivative or proanthocyanidin containing concentrate, D-mannose are effective together for binding to E. coli to aid in flushing the E. coli from the urinary tract system while preventing binding of E. coli to cells in the urinary tract system.
Owner:US NUTRACEUTICALS LLC
A kind of calculus tea composition and preparation method thereof
ActiveCN102266501ANormal frequency of urinationGood curative effectUrinary disorderPlant ingredientsUrinary catheterUpper urinary tract infection
The invention relates to a Jieshitong tea composition and a preparation method thereof. The Jieshitong tea composition is prepared from eight Chinese medicines of snowbell-leaf tickclover herb, corn stigma, abrus herb, tuckahoe, pyrrosia leaf, lalang grass rhizome, plantain herb and lygodium. The Jieshitong tea composition has the effects of inducing diuresis and diminishing inflammation, treating stranguria and relieving pain and stopping bleeding and eliminating stone, and is mainly used for urinary tract infection, cystitis, nephritis edema, lithangiuria, hematuresis, turbid dribbling and causalgia in urinary catheter. Clinical pharmacodynamic tests prove that the Jieshitong tea composition is obvious in an effect and high in bioavailability and does not have toxic or side effect.
Owner:王疆宏
Equipment, kit and method for microbiological diagnosis
InactiveUS6537772B1Easy to manageSimple interfaceBioreactor/fermenter combinationsBiological substance pretreatmentsPeristaltic pumpMicrocomputer
The present invention is related to microbiology and forms part of a system for rapid microbiological diagnosis. The invention allows detection of turbidimetric changes due to microbial growth, using equipment comprised of two main devices: a static turbidimetric minireader and a microflow sensor which is fed by a peristaltic pump; this equipment is coupled to a microcomputer with a program package for acquisition, processing and formation of databases used in generating necessary reports.The diagnostic kit has a glass vial with culture medium and a polymer with derepressive activity and two additional substrates for E.coli identification, as well as a set of antibiotic discs arranged in a strip for antibiogram determination from previously isolated colonies or samples obtained directly from their sources, allowing detection of urinary tract infections from direct samples of urine, and additionally simultaneous identification of E.coli.
Owner:CENT NACIONAL DE INVESTIGACIONES CIENTIFICAS (CINC)
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
ActiveUS9149522B2Efficient and cost-effectiveLittle aggregationInorganic non-active ingredientsLyophilised deliveryEscherichia coliAdjuvant
This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
Owner:SEQUOIA VACCINES INC
Ostomy bag undergarment
InactiveUS20020016578A1Non-surgical orthopedic devicesColostomyUpper urinary tract infectionEngineering
A shorts-type undergarment with an inner pocket (1) secured to the waistband (6) having a U-shaped cutout (2) where the flange (8a) of an ostomy bag (8c) is situated. Said inner pocket (1) is attached to the waistband (6) and holds and ostomy bag (8c). At the bottom of the inner pocket (1) is a horizontal strip of oppositely mated Velcro strips (9) which can be detached to allow the exit of the bag's tube to dispose of the accumulated bodily fluids. It has two vertical openings on the front of the shorts. The first opening, 4, is located at the bottom of the crotch and extends upward. This opening, 4, allows for the insertion of a catheter. The second opening, is an access panel, 1, which is opened by pulling back a long vertical strip of Velcro(R), 3, attached to a corresponding strip of oppositely mated Velcro(R), 2, which horizontally extends partially across one front side. The patient is able to retain a high degree of modesty and dignity, when the catheter is attended to by medical personnel. Since the catheter is secured, in a straight pathway, there is a decreased likelihood the patient will develop secondary medical complications like urinary tract infections, discomfort and irritation associated with a catheter which is not properly secured.
Owner:GUPTON KENNETH
Compositions and means for diagnosing microbial infections
ActiveUS20090068696A1Sure easyEasy to detectMicrobiological testing/measurementBiochemistry apparatusMicroorganismUpper urinary tract infection
The present invention pertains to the need for novel, reliable, fast and inexpensive approaches to diagnosing, including detecting and characterising microbial infections in humans and animals or methods for detecting and characterising microbial infections in various environments, such as in a food or feed sample.The present invention provides compositions, platforms, kits and methods for diagnosing, detecting and / or characterising a microbial infection or contamination. In particular the present invention relates to such compositions, platforms, kits and methods for diagnosing, detecting and / or characterising a urinary tract infection.
Owner:SSI DIAGNOSTICA AS
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
ActiveUS9017698B2Slight aggregation slightSmall sizeInorganic non-active ingredientsLyophilised deliveryEscherichia coliUpper urinary tract infection
This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
Owner:SEQUOIA VACCINES INC
Method of preventing, controlling and ameliorating urinary tract infections and supporting digestive health by using a synergistic cranberry derivative, a d-mannose composition and a proprietary probiotic blend
InactiveUS20110064706A1Preventing, controlling or ameliorating urinary tract infectionsReduced pHBiocideOrganic active ingredientsEscherichia coliDry weight
A method and composition prevents, controls and ameliorates urinary tract infections caused by E. coli by administering a therapeutically effective amount of a human dietary supplement composition comprising a cranberry derivative or proanthocyanidin containing concentrate, D-mannose and a proprietary probiotic blend. The cranberry derivative or proanthocyanidin containing concentrate comprises from about one percent (1.0%) by weight to about 95 percent (95.0%) by weight on a dry weight basis. The composition is formulated for delivering a D-mannose unit dosage between about 0.5 to about 5.0 grams per dose. A proprietary probiotic blend is included to provide 5 billion CFU per dose.
Owner:US NUTRACEUTICALS LLC
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
ActiveUS9149521B2Efficient and cost-effectiveLittle aggregationInorganic non-active ingredientsLyophilised deliveryEscherichia coliAdjuvant
This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
Owner:SEQUOIA VACCINES INC
Pharmaceutical composition for treating diseases of urinary system and method for detecting components thereof
ActiveCN101700367AImprove stone removal effectGood curative effectUrinary disorderPlant ingredientsDiseaseUpper urinary tract infection
Owner:JIANGXI HONGXING PHARMA
Application of Rakicidins compounds in resistance to clinical pathogenic anaerobic bacteria
ActiveCN105709205AQuite activeStrong inhibitory activityAntibacterial agentsBacteriaDiseaseUpper urinary tract infection
The invention relates to the field of biological medicine, in particular to an application of Rakicidins compounds in resistance to clinical pathogenic anaerobic bacteria. Pharmacodynamic experiments indicate that the Rakicidins compounds have good resistant effect on the clinical pathogenic anaerobic bacteria and have the resistant effect on vancomycin enterococcus infection diseases. The Rakicidins compounds can be used for treating diarrhea, enteritis, alimentary infection, oral infection or skin acne caused by clostridium difficile as well as diseases such as urinary tract infection, or skin soft-tissue infection and the like.
Owner:FUJIAN INST OF MICROBIOLOGY
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
ActiveUS9504743B2Efficient and cost-effectiveLittle aggregationInorganic non-active ingredientsAntibody medical ingredientsEscherichia coliUpper urinary tract infection
This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including Escherichia coli and multi-drug resistant E. coli. This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including E. coli and multi-drug resistant E. coli.
Owner:SEQUOIA VACCINES INC
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com